main content start
0 Saved

Experience

0yrs

Location

Tung Shin Hospital

Groups

Upcoming Webinar

Start bookmarking content to consume it later

Start bookmarking content to consume it later

Start bookmarking content to consume it later

nasopharyngeal carcinoma • 46 Min Watch

Comprehensive Overview of Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is an undifferentiated form of squamous cell carcinoma emerging from the epithelium of nasopharyn

nasopharyngeal carcinoma Immunotherapy

1

Watch Now

nasopharyngeal carcinoma • 46 Min Watch

Comprehensive Overview of Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is an undifferentiated form of squamous cell carcinoma emerging from the epithelium of nasopharyn

nasopharyngeal carcinoma Immunotherapy

1

Watch Now

Breast Cancer • 45 Min Watch

Expert Perspective - How I Treat Metastatic Her2 Positive Breast Cancer

Anti-HER2 directed therapy remains the cornerstone of care for individuals with HER2-positive metastatic breast cancer (MBC). In the majority of cases...

anti-her2 directed therapy her2-positive metastatic breast cancer expert perspective algorithm for management of her2 positive mbc

2

Watch Now

Breast Cancer • 45 Min Watch

Expert Perspective - How I Treat Metastatic Her2 Positive Breast Cancer

Anti-HER2 directed therapy remains the cornerstone of care for individuals with HER2-positive metastatic breast cancer (MBC). In the majority of cases...

anti-her2 directed therapy her2-positive metastatic breast cancer expert perspective algorithm for management of her2 positive mbc

1

Watch Now

Myelodysplastic Syndromes • 34 Min Watch

Low Risk MDS - Key Practice Points

Myelodysplastic Syndromes (MDS) or Myeloproliferative Neoplasms show considerable heterogeneity with respect to presence of anemia , cytopenia & molec...

ipss -m low risk molecular features

1

Watch Now

Myelodysplastic Syndromes • 34 Min Watch

Low Risk MDS - Key Practice Points

Myelodysplastic Syndromes (MDS) or Myeloproliferative Neoplasms show considerable heterogeneity with respect to presence of anemia , cytopenia & molec...

ipss -m low risk molecular features

1

Watch Now

Breast Cancer • 45 Min Watch

Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

Immune cells known as

tumor-infiltrating lymphocytes (tils) promising biomarker

1

Watch Now

Breast Cancer • 45 Min Watch

Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

Immune cells known as

tumor-infiltrating lymphocytes (tils) promising biomarker

1

Watch Now

Breast Cancer • 18 Min Watch

ABC-6 Guidelines : An Overview , Part -1

International Consensus Conference for Advanced Breast Cancer (ABC): publishes consensus-based guidelines which are adopted and adapted by m...

abc -6 guidelines cancer related cognitive impairment endocrine resistance oligometastatic disease

5

Watch Now

Breast Cancer • 18 Min Watch

ABC-6 Guidelines : An Overview , Part -1

International Consensus Conference for Advanced Breast Cancer (ABC): publishes consensus-based guidelines which are adopted and adapted by m...

abc -6 guidelines cancer related cognitive impairment endocrine resistance oligometastatic disease

5

Watch Now

MedCourse • 10 Min Watch

Hot topics em doenças infecciosas: abordagem prática e desafios emergentes

Hot topics em doenças infecciosas: abordagem prática e desafios emergentes

tipos de imunodeficiências/imunossupressores visão geral infecções associadas a transplantes de órgãos sólidos melhorando o diagnóstico infecções virais fúngicas

1

Watch Now

MedCourse • 12 Min Watch

Infecções MRSA & VRSA: epidemiologia, resistência, mecanismos, diagnóstico, guidelines e conduta terapêutica

Epidemiologia, Resistência e mecanismos & Diagnóstico de MRSA e VRSA

mrsa e vrsa

1

Watch Now

Multiple Myeloma • 18 Min Watch

Exploring Optimal Duration of Lenalidomide Maintenance after ASCT

Best evidence for Lenalidomide maintenance after ASCT came from Meta-analysis of 3 trials (McCarthy et al, JCO 207) confirmed significant OS benefit w...

lenalidomide maintenance myeloma XI duration of maintenance

0

Watch Now

Multiple-Myeloma • 22 Min Watch

Importance of identifying High Risk Patients in Multiple Myeloma

N/A

high risk myeloma

2

Watch Now

Myelodysplastic Syndromes • 00 Min Watch

Factors that influence treatment adherence and outcomes in MDS

Anticipate & manage adverse events to optimize treatment outcomes: Patients treated with hypomethylating agents are at increased risk of cytopenias & ...

adverse events hypomethylating agents mds treatment compliance

0

Watch Now

Myelodysplastic Syndromes • 38 Min Watch

Duration of treatment does it improve outcomes Hypomethylating agents in MD

.

duration of treatment hypomethylating agents mds

1

Watch Now
Hi, can I help?
Chat SupportX
Support Team
Hello, how can I help you today?
Please select one of the below options.

Find Information

Unable to Login or Register

Want to share feedback